Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A11 | P48066 | 7/20 | 0.37 |
| ▸ | SLC6A1 | P30531 | 3/20 | 0.37 |
| ▸ | SLC6A12 | P48065 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SLC6A13 | Q9NSD5 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2997021 | 0.90 | SLC6A11 (0.37) | SLC6A11SLC6A1SLC6A12CYP1A2CYP3A4 | |
| SCHEMBL21662396 | 0.84 | SLC6A11 (0.36) | SLC6A11SLC6A1SLC6A12CYP1A2CYP3A4 | |
| SCHEMBL26302696 | 0.83 | SLC6A11 (0.33) | SLC6A11SLC6A1SLC6A12CYP1A2CYP3A4 | |
| SCHEMBL16299839 | 0.80 | SLC6A11 (0.35) | SLC6A11SLC6A1SLC6A12CYP1A2CYP3A4 | |
| SCHEMBL11992564 | 0.80 | SLC6A1 (0.33) | SLC6A11SLC6A1 | |
| SCHEMBL16938709 | 0.79 | SLC6A1 (0.32) | SLC6A11SLC6A1ALDH1A1 | |
| SCHEMBL4358633 | 0.79 | APP (0.31) | — | |
| SCHEMBL11992573 | 0.78 | SLC6A11 (0.34) | SLC6A11SLC6A1SLC6A12CYP1A2CYP3A4 | |
| SCHEMBL4013956 | 0.78 | APP (0.31) | — | |
| SCHEMBL12209383 | 0.76 | ALDH1A1 (0.34) | SLC6A11SLC6A1CYP1A2CYP3A4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1430147-B1 | FLUORESCENT QUENCHING DETECTION REAGENTS AND METHODS | EPOCH BIOSCIENCES INC (US) | 2013-05-22 | — | — | EP | disclosed |
| US-20100174058-A1 | FLUORESCENT QUENCHING DETECTING REAGENTS AND METHODS | ELITECHGROUP, INC. | 2010-07-08 | — | — | US | disclosed |
| US-7662942-B2 | Oligonucleotide probes containing two labels useful in hybridization assays | Elitech Holdings, B.V. (NL) | 2010-02-16 | — | — | US | disclosed |
| EP-1430147-A4 | FLUORESCENT QUENCHING DETECTION REAGENTS AND METHODS | EPOCH BIOSCIENCES INC (US) | 2008-06-25 | — | — | EP | disclosed |
| US-20060292589-A1 | Oligonucleotide probes containing two labels useful in hybridization assays | EPOCH BIOSCIENCES, INC. (US) | 2006-12-28 | — | — | US | disclosed |
| US-20040191796-A1 | Fluorescent quenching detection reagents and methods | EPOCH PHARMACEUTICALS, INC. (US) | 2004-09-30 | — | — | US | disclosed |
| US-6790945-B2 | OLIGONUCLEOTIDE PROBES CONTAINING TWO LABELS USEFUL IN HYBRIDIZATION ASSAYS | EPOCH BIOSCIENCES, INC. | 2004-09-14 | — | — | US | disclosed |
| EP-1430147-A1 | FLUORESCENT QUENCHING DETECTION REAGENTS AND METHODS | Epoch Biosciences, Inc. (US) | 2004-06-23 | — | — | EP | disclosed |
| WO-2002099141-A9 | FLUORESCENT QUENCHING DETECTION REAGENTS AND METHODS | EPOCH BIOSCIENCES INC (US) | 2004-05-27 | — | — | WO | disclosed |
| US-20040081959-A9 | Using oligonucleotide detectors; hybridization analyzing | EPOCH BIOSCIENCES, INC. (US) | 2004-04-29 | — | — | US | disclosed |
| US-6727356-B1 | AS PROBES SUCH AS FOR FLUORESCENCE RESONANCE ENERGY TRANSFER; QUENCHER INCLUDES A 4-(PHENYLDIAZENYL)PHENYLAMINE STRUCTURE; IMPROVED SIGNAL TO NOISE RATIO AND HYBRIDIZATION | EPOCH PHARMACEUTICALS, INC. | 2004-04-27 | — | — | US | disclosed |
| US-6653473-B2 | Nucleotide sequences for use as diagnostic tool in genetic analysis | EPOCH BIOSCIENCES, INC. | 2003-11-25 | — | — | US | disclosed |
| US-20030096254-A1 | Enhancing resonance ability of oligonuclotide probes for use in hybridization assays; gene expression | EPOCH BIOSCIENCES, INC. (US) | 2003-05-22 | — | — | US | disclosed |
| US-20030008304-A1 | Fluorescent quenching detection reagents and methods | EPOCH BIOSCIENCES, INC. (US) | 2003-01-09 | — | — | US | disclosed |
| WO-2002099141-A1 | FLUORESCENT QUENCHING DETECTION REAGENTS AND METHODS | EPOCH BIOSCIENCES, INC. (US) | 2002-12-12 | — | — | WO | disclosed |
| US-20020034754-A1 | Fluorescent quenching detection reagents and methods | ELITECHGROUP, INC. | 2002-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030008304-A1 | Fluorescent quenching detection reagents and methods | DDX5, DDX21, DCLRE1B | SLC6A11 2202/4885SLC6A1 2029/4885SLC6A12 2656/4885 |
| US-20020034754-A1 | Fluorescent quenching detection reagents and methods | DDX5, DDX21, DCLRE1B | SLC6A11 2202/4885SLC6A1 2029/4885SLC6A12 2656/4885 |
| US-20100174058-A1 | FLUORESCENT QUENCHING DETECTING REAGENTS AND METHODS | DDX5, DDX21, DCLRE1B | SLC6A11 2414/4885SLC6A1 2173/4885SLC6A12 2905/4885 |
| US-20040081959-A9 | Using oligonucleotide detectors; hybridization analyzing | DCLRE1B, DDX21, DDX41 | SLC6A11 3908/4885SLC6A1 4081/4885SLC6A12 4564/4885 |
| US-20060292589-A1 | Oligonucleotide probes containing two labels useful in hybridization assays | DCLRE1B, DDX21, DCLRE1A | SLC6A11 4000/4885SLC6A1 4221/4885SLC6A12 4472/4885 |
| US-20040191796-A1 | Fluorescent quenching detection reagents and methods | DDX5, IPO4, DBF4 | SLC6A11 3949/4885SLC6A1 3788/4885SLC6A12 3400/4885 |
| US-20030096254-A1 | Enhancing resonance ability of oligonuclotide probes for use in hybridization assays; gene expression | DCLRE1B, SNRPE, ZFR | SLC6A11 2874/4885SLC6A1 2661/4885SLC6A12 2988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.